Role of invariant natural killer T cells in immune regulation and as potential therapeutic targets in autoimmune disease.

Van Kaer L
Expert Rev Clin Immunol. 2006 2 (5): 745-57

PMID: 20477630 · DOI:10.1586/1744666X.2.5.745

Autoimmune diseases are caused by pathogenic antibody and/or T-cell responses that are left unchecked by regulatory immune mechanisms. Recent studies in immunology have focused on subsets of regulatory T cells (T(regs)) that can suppress autoimmune responses. Invariant natural killer T (iNKT) cells are a subset of T(regs) that recognize glycolipid antigens in the context of CD1d proteins. iNKT cells play a suppressive role in several autoimmune diseases and, therefore, are attractive targets for development of immunotherapies for these diseases. While preclinical studies with reagents, such as the sea sponge-derived iNKT-cell antigen alpha-galactosylceramide, have been promising, there are substantial concerns about treating humans with autoimmunity, or at risk of developing autoimmunity, with these reagents.

MeSH Terms (0)

Connections (1)

This publication is referenced by other Labnodes entities: